RPg Family Wealth Advisory »

Halozyme Therapeutics shares owned by RPg Family Wealth Advisory

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by RPg Family Wealth Advisory from 13F filings

Historical chart of RPg Family Wealth Advisory investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by RPg Family Wealth Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by RPg Family Wealth Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9M 33k 57.24

More positions owned by RPg Family Wealth Advisory

J P Morgan Exchange-Traded FD TR Ultra-Short Income ETF Common Stock (JPST)
Amazon.Com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc Cap STK Common Stock (GOOGL)
Facebook Inc-Class A Common Stock (META)
Howmet Aerospace Common Stock (HWM)
Tenet Healthcare Corp Common Stock (THC)
Microsoft Common Stock (MSFT)
Verizon Common Stock (VZ)
Nvidia Corp Common Stock (NVDA)
SPDR Bloomberg Barclays International Treasury Bond ETF Common Stock (BWX)
UBS Group Common Stock (UBS)
DBX ETF TR Xtrackers MSCI USA Esg Leaders Equity ETF Common Stock (USSG)
Visa Inc Com CL A Common Stock (V)
Bitwise Bitcoin ETF TR SHS Ben Int Common Stock (BITB)

View all positions for RPg Family Wealth Advisory

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Bank of America Corporation
Arrowpoint Asset Management
Goldman Sachs Group
Handelsbanken Fonder AB
Congress Asset Management
Invesco

View all funds holding Halozyme Therapeutics